Ceva Animal Health and Mitsui & Co. announce the creation of Ceva Bussan Animal Health, a Joint Venture in the Japanese animal health market further reinforcing the strategic collaboration between Ceva and Mitsui.

Libourne (France) / Tokyo (Japan), May 8th 2026 — Ceva Animal Health (Ceva) and Mitsui & Co., Ltd. (Mitsui) today announce the creation of Ceva Bussan Animal Health, a new joint venture that brings together Bussan Animal Health (BAH) and Ceva Japan. As part of the transaction, Mitsui has transferred 60% of its shareholding in BAH to Ceva. Ceva Bussan Animal Health will be operated by Ceva as a controlling shareholder and benefit from Mitsui’s ongoing support as a leading global trading and investment company headquartered in Japan.

In parallel, Mitsui has made an additional strategic equity investment in Ceva, further reinforcing the long-standing partnership between Ceva and Mitsui.

Strengthening the strategic collaboration between Ceva and Mitsui

Ceva and Mitsui have built a long-standing strategic partnership in the animal health sector, combining Ceva’s global expertise as a leading animal health company with Mitsui’s extensive global reach and diverse business portfolio.

This enhanced partnership is intended to accelerate collaboration across broader initiatives, including innovation, market expansion and the creation of long-term sustainable value in the animal health industry.

Ceva Bussan Animal Health represents a cornerstone of this reinforced collaboration, providing a concrete operational platform in Japan.

A new full-line animal health company

Ceva Bussan Animal Health combines BAH’s 75-year heritage in the Japanese animal health market with Ceva’s position as a global top five animal health company. BAH brings a strong and longstanding presence in the veterinary channel, while Ceva provides access to leading livestock and pet products, and to future innovation. Ceva also adds recognized multichannel expertise, particularly in OTC pet products. Together, these complementary capabilities create a company with a broader and more complete product range for the Japanese market.

BAH generated approximately €40 million in revenue in 2025 with deep experience serving veterinarians and pet owners.

Ceva Japan contributes a lean team with robust commercial, marketing and regulatory capabilities and a solid portfolio with existing and future products covering swine, ruminant and pet health products.

Ceva Bussan Animal Health: a strengthened platform for growth in Japan

The creation of Ceva Bussan Animal Health marks a significant step in reinforcing Ceva and Mitsui’s long-term commitment to the Japanese animal health market. By uniting the teams and operations of BAH and Ceva Japan within a single structure, the joint venture gains the scale and strategic coherence needed to accelerate its development, expand its reach and operate more efficiently in a fast-evolving market.

Ceva Bussan Animal Health will serve as a consolidated platform to deepen customer engagement, support future product introductions, and strengthen the company’s position in one of the world’s most strategic animal health markets.

As part of the new governance, Mr. Tadahiro Ohashi, former Managing Director of Ceva Japan, has been appointed CEO of Ceva Bussan Animal Health, providing a clear strategic direction and an action-oriented and result-driven mindset.

Mr. Akito Umeda, former CEO of BAH, will serve as Deputy CEO of Ceva Bussan Animal Health, ensuring continuity and bringing extensive managerial experience.

Marc Prikazsky, Executive chairman of Ceva Animal Health, commented:

“With Ceva Bussan Animal Health, we are opening a new chapter for animal health in Japan. By combining the deep roots and expertise of BAH with Ceva’s global innovation capabilities, we are creating a company uniquely positioned to better serve veterinarians, farmers, and pet owners. This joint venture reflects our long-standing commitment to the Japanese market and our ambition to accelerate growth by building strong, local partnerships. Together with Mitsui, we are laying the foundations for a stronger, more dynamic future for animal health in Japan.”

Toshitaka Inuzuka, COO of Nutrition & Agriculture Business Unit, Mitsui & Co., commented: “We are very pleased that this allows Mitsui and Ceva to further deepen our collaboration. Leveraging its broad portfolio of business assets and global network, Mitsui has long been committed to creating new growth opportunities in the animal health market. Ceva Bussan Animal Health will serve as a core platform in Japan underpinning the collaboration between Mitsui and Ceva, combining the respective strengths of BAH and Ceva to support the sustainable growth of the Japanese animal health market.

Through continued collaboration with Ceva, we remain committed to contributing to the further development of the animal health industry.“